AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2015

Jun 17, 2015

32870_dirs_2015-06-17_10535337-2a32-4e31-bc7e-6551f58031dc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2015-06-16

Reporting Person: SULLIVAN LOUIS W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-16	Common Stock	M	13457	$10.28	Acquired	41957	Direct
2015-06-16	Common Stock	S	13457	$31.325	Disposed	28500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-16	Stock Option	$10.28	M	13457	Disposed	2016-06-30	Common Stock (13457)	Direct

Footnotes

F1: Consists of an option granted under the company's stock incentive plan on June 30, 2006.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.25 to $31.65, inclusive.

F3: The option vested in three equal installments in June 2007, 2008 and 2009.